Early Detection of Vascular Dysfunction Using Biomarkers From Lagrangian Carotid Strain Imaging

CompletedOBSERVATIONAL
Enrollment

217

Participants

Timeline

Start Date

September 9, 2021

Primary Completion Date

June 30, 2025

Study Completion Date

June 30, 2025

Conditions
HealthyCarotid Artery Diseases
Interventions
DEVICE

Ultrasound imaging

Carotid artery ultrasound exam. US imaging will include complete clinical carotid ultrasound examination (B-mode, Doppler and color-flow modes), clinical strain and shear wave imaging study, backscattered and beam-steered radiofrequency (RF) data acquisition using research mode, and reference phantom RF data acquisition.

DEVICE

Magnetic Resonance Imaging (MRI)

Head and Neck MRI exam with contrast

OTHER

Neurocognitive testing

Harmonization battery to assess executive function/attention, speeded psychomotor, verbal, and nonverbal memory, language, and visuospatial skills

DEVICE

Transcranial Doppler (TCD)

Use of a TCD system to monitor right and left middle cerebral artery Doppler waveforms in the volunteer for 60 minutes

DEVICE

Pulse Wave Doppler

Pulse wave Doppler will be used to acquire a Doppler waveform in the right common carotid artery and the right femoral artery

Trial Locations (1)

53705

Department of Medical Physics, University of Wisconsin, Madison

All Listed Sponsors
collaborator

National Heart, Lung, and Blood Institute (NHLBI)

NIH

lead

University of Wisconsin, Madison

OTHER

NCT04632485 - Early Detection of Vascular Dysfunction Using Biomarkers From Lagrangian Carotid Strain Imaging | Biotech Hunter | Biotech Hunter